Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40
Author:
Affiliation:
1. Banner Sun Health Research Institute, Sun City, AZ, USA
2. Avid Radiopharmaceuticals, Philadelphia, PA, USA
3. Barrow Neurological Institute, Phoenix, AZ, USA
Publisher
IOS Press
Subject
Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience
Reference44 articles.
1. Theoretical impact of Florbetapir (18F) amyloid imaging on diagnosis of Alzheimer dementia and detection of preclinical cortical amyloid;Beach;J Neuropathol Exp Neurol,2014
2. Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates;Dugger;J Neuropathol Exp Neurol,2014
3. Use of florbetapir-PET for imaging beta-amyloid pathology;Clark;JAMA,2011
4. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: A prospective cohort study;Clark;Lancet Neurol,2012
5. Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density;Curtis;JAMA Neurol,2015
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer’s Disease Using Quantitative Systems Pharmacology Model;Drugs;2024-06-20
2. Predicting conversion from mild cognitive impairment to Alzheimer’s disease: a multimodal approach;Brain Communications;2024
3. A combined physiologically‐based pharmacokinetic and quantitative systems pharmacology model for modeling amyloid aggregation in Alzheimer's disease;CPT: Pharmacometrics & Systems Pharmacology;2023-01-20
4. Diagnostic Biomarkers of Amyloid and Tau Pathology in Alzheimer’s Disease: An Overview of Tests for Clinical Practice in the United States and Europe;The Journal Of Prevention of Alzheimer's Disease;2023
5. Focal amyloid and asymmetric tau in an imaging-to-autopsy case of clinical primary progressive aphasia with Alzheimer disease neuropathology;Acta Neuropathologica Communications;2022-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3